Neuropathic pain and quality of life

European Journal of Pain

Volumn 6, Issue SUPPL. B, 2002, Pages 19-24

  Rowbotham, David J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Neuropathic pain; Quality of life

Indexed keywords

LAMOTRIGINE;

CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; NEUROPATHY; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM;

EID: 0036397685     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.2001.0317     Document Type: Conference Paper

References (51)

1. Ahroni JH, Boyko EJ. Responsiveness of the SF-36 among veterans with diabetes mellitus. J Diabetes Complications 2000; 14: 31-39.
2. Anke AGW, Stenehjem AE, Stanghelle JK. Pain and life quality within 2 years of spinal cord injury. Paraplegia 1995; 33: 555-559.
3. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E, for the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomized controlled trial. JAMA 1998; 280: 1831-1836.
4. Becker N, Bondegaard TA, Olsen AK, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 1997; 73: 393-400.
5. Becker N, Hojsted J, Sjogren P, Eriksen J. Sociodemographic predictors of treatment outcome in chronic non-malignant pain patients. Do patients receiving or applying for Disability Pension benefit from multidisciplinary pain treatment?. Pain 1998; 77: 279-287.
6. Becker N, Sjogren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000; 84: 203-211.
7. Benjamin S, Lennon S, Gardner G. The validity of the General Health Questionnaire for first-stage screening for mental illness in pain clinic patients. Pain 1991; 47: 197-202.
8. Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the SCL-90-R with low-back pain patients. Spine 1994; 19: 42-48.
9. Blumenschein K, Johannesson M. Incorporating quality of life changes into economic evaluations of health care: an overview. Health Policy 1996; 36: 155-166.
10. Brazier J. The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation. Pharmacoeconomics 1995; 7: 403-415.
11. Brazier JE, Harper R, Jones NB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992; 305: 160-164.
12. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
13. Brown J, Klapow J, Doleys D, Lowery D, Tutak U. Disease-specific and generic health outcomes: a model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients. Clin J Pain 1999; 15: 122-131.
14. Cleeland CS. Assessment of pain in cancer. Adv Pain Res Ther 1990; 16: 47.
15. Dougherty CJ. Quality-adjusted life years and the ethical values of health care. Am J Phys Med Rehabil 1995; 74(Suppl 1): S29-S33.
16. Ebrahim S, Barer D, Nouri F. Use of the Nottingham Health Profile with patients after a stroke. J Epidemiol Community Health 1986; 40: 166-169.
17. Follick MJ, Smith TW, Ahern DK. The sickness impact profile: a global measure of disability in chronic low back pain. Pain 1985; 21: 67-76.
18. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000a; 47: 123-128.
19. Galer BS, Henderson J, Perander J, Jensen MP. Course of symptoms and quality of life measurement in complex regional pain syndrome: a pilot survey. J Pain Symptom Manage 2000b; 20: 286-292.
20. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 1993; 306: 1440-1444.
21. Ghaly AFF. The psychological and physical benefits of pelvic ultrasonography in patients with chronic pelvic pain and negative laparoscopy. A random allocation trial. J Obstet Gynaecol 1994; 14: 269-271.
22. Hadjistavropoulos HD, MacLeod FK, Asmundson GG. Validation of the Chronic Pain Coping Inventory. Pain 1999; 80: 471-481.
23. Hardt J, Gerbershagen HU, Franke P. The symptom check-list, SCL-90-R: its use and characteristics in chronic pain patients. Eur J Pain 2000; 4: 137-148.
24. Houssien DA, McKenna SP, Scott DL. The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 1997; 36: 69-73.
25. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine 1998; 23: 2591-2600.
26. Jensen MP, Strom SE, Turner JA, Romano JM. Validity of the Sickness Impact Profile Roland scale as a measure of dysfunction in chronic pain patients. Pain 1992; 50: 157-162.
27. Kemler MA, De Vet HCW. Health-related quality of life in chronic refractory reflex sympathetic dystrophy (Complex Regional Pain Syndrome type I). J Pain Symptom Manage 2000; 20: 68-76.
28. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23: 354-356.
29. Leggett S, Mooney V, Matheson LN, Nelson B, Dreisinger T, van Zytveld J, Vie L. Restorative exercise for clinical low back pain. A prospective two-center study with 1-year follow-up. Spine 1999; 24: 889-898.
30. Lindesay J. Validity of the General Health Questionnaire (GHQ) in detecting psychiatric disturbance in amputees with phantom pain. J Psychosom Res 1996; 30: 277-281.
31. Luscombe FE, Wallace L, Williams J, Griffiths DG. A District General Hospital pain management programme: first year experiences and outcomes. Anaesthesia 1995; 50: 114-117.
32. Mauskopf J, Austin R, Dix L, Berzon R. The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity. Qual Life Res 1994; 3: 431-435.
33. Mauskopf JA, Paul JE, Grant DM, Stergachis A. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 1998; 13: 277-288.
34. McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double blind, placebo controlled trial. Pain 1999; 83: 105-107.
35. McGregor NR, Butt HL, Zerbes M, Klineberg IJ, Dunstan RH, Roberts TK. Assessment of pain (distribution and onset), symptoms, SCL-90-R inventory responses, and the association with infectious events in patients with chronic orofacial pain. J Orofacial Pain 1996; 10: 339-350.
36. Melzack R. The McGill pain questionnaire. Pain 1975; 1: 277-299.
37. Melzack R. The short-form McGill pain questionnaire. Pain 1987; 30: 191-197.
38. Morley S, Pallin V. Scaling the affective domain of pain: a study of the dimensionality of verbal descriptors. Pain 1995; 62: 39-49.
39. O'Reilly SC, Jones A, Muir KR, Doherty M. Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis 1998; 57: 588-594.
40. Penny KI, Purves AM, Smith BH, Chambers WA, Smith WC. Relationship between the chronic pain grade and measures of physical, social and psychological well-being. Pain 1999; 79: 275-279.
41. Purves AM, Penny KI, Munro C, Smith BH, Grimshaw J, Wilson B. Defining chronic pain for epidemiological research. Assessing a subjective definition. Pain Clin 1998; 10: 139-147.
42. Rae SA, Blood SJ, Ivens M, Penney C. Designing a back management service: the Exeter experience and first year results. Clin Rehabil 1998; 12: 354-361.
43. Rice ASC, Maton S, and the Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double-blind, placebo-controlled study. Pain 2001; 94: 215-224.
44. Riley IIJ, Zawacki TM, Robinson ME, Geisser ME. Empirical test of the factor structure of the West Haven-Yale multidimensional pain inventory. Clin J Pain 1999; 15: 24-30.
45. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA 1998; 280: 1837-1842.
46. Smith BH, Penny KI, Purves AM, Munro C, Wilson B, Grimshaw J, Chambers WA, Smith WC. The chronic pain grade questionnaire: validation and reliability in postal research. Pain 1997; 71: 141-147.
47. Snaith RP. The hospital anxiety and depression scale. Br J Gen Pract 1990; 40: 305.
48. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware Jr. JE. Functional status and well-being of patients with chronic study. Results from the medical outcomes study. JAMA 1989; 262: 907-913.
49. Tauschke E, Merskey H, Helmes E. Psychological defence mechanisms in patients with pain. Pain 1990; 40: 161-170.
50. Underwood MR, Barnett AG, Vickers MR. Evaluation of two time-specific back pain outcome measures. Spine 1999; 24: 1104-1112.
51. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.